SCHEMBL5480685

SCHEMBL5480685

CCc1cccc2nc(N)n(CCCN(C)C(C)=O)c12

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 7/20 0.48
CXCR4 P61073 1/20 0.38
ALDH1A1 P00352 1/20 0.38
DYRK1A Q13627 2/20 0.37
POLB P06746 1/20 0.36
CXCR3 P49682 1/20 0.36
MTNR1A P48039 2/20 0.35
MTNR1B P49286 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
HTT P42858 1/20 0.35
LMNA P02545 1/20 0.35
PKM P14618 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
PRMT5 O14744 1/20 0.35
ELANE P08246 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5468452 0.87 TLR8 (0.45) TLR8CXCR4CXCR3LMNA
SCHEMBL5473914 0.86 PRMT5 (0.49) TLR8CXCR4ALDH1A1DYRK1ACXCR3
SCHEMBL5465854 0.81 TLR8 (0.66) TLR8CXCR4POLBCYP1A2CYP2D6
SCHEMBL5453372 0.80 TLR8 (0.41) TLR8ALDH1A1POLBCXCR3CYP1A2
SCHEMBL5454116 0.78 POLB (0.58) TLR8CXCR4POLBCYP1A2CYP2D6
SCHEMBL5480691 0.77 MTNR1A (0.55) TLR8ALDH1A1POLBMTNR1AMTNR1B
SCHEMBL5453997 0.77 TLR8 (0.53) TLR8CXCR4ALDH1A1POLBLMNA
SCHEMBL5451191 0.75 CYP1A2 (0.56) TLR8CXCR4ALDH1A1POLBCYP1A2
SCHEMBL14373235 0.74 PRMT5 (0.43) TLR8CXCR4ALDH1A1CXCR3HTT
SCHEMBL5463793 0.74 TLR8 (0.49) TLR8ALDH1A1POLBCYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070232673-A1 2-Imino-benzimidazoles ABBOTT LABORATORIES 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232673-A1 2-Imino-benzimidazoles CYP2C19, UGT2B7, UGT2B17 TLR8 3837/4885CXCR4 3445/4885ALDH1A1 39/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.